Cerivastatin: the low-dose HMG-COA reductase inhibitor

By Tikkanen M.J.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 1, 2000-01 ,pp. : 161-166

Informa Healthcare

Access to resources Recommend Favorite

Crilvastatin, a new 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, inhibits cholesterol absorption in genetically hypercholesterolemic rats

By Hajri T.   Ferezou J.   Laurelle C.   Lutton C.  

European Journal of Pharmacology, Vol. 286, Iss. 2, 1995-11 ,pp. : 131-136

Elsevier

Access to resources Recommend Favorite

Reduction of Plasma Cholesterol Levels and Induction of Hepatic LDL Receptor by Cerivastatin Sodium (CAS 143201-11-0, BAY w 6228), a New Inhibitor of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase, in Dogs

By Yasunobu Yuji   Hayashi Kozo   Shingu Tetsuji   Nomura Katsuhiko   Ohkura Yoshifumi   Tanaka Kouichi   Kuga Yoshio   Nomura Syu-ichi   Ohtani Harumi   Nishimura Takaharu   Matsuura Hideo   Kajiyama Goro  

Cardiovascular Drugs and Therapy, Vol. 11, Iss. 4, 1997-09 ,pp. : 567-574

Springer Publishing Company

Access to resources Recommend Favorite

EFFECT OF THE NEW HMG-CoA REDUCTASE INHIBITOR CERIVASTATIN (BAY W 6228) ON MIGRATION, PROLIFERATION AND CHOLESTEROL SYNTHESIS IN ARTERIAL MYOCYTES

By Corsini A.   Arnaboldi L.   Raiteri M.   Quarato P.   Faggiotto A.   Paoletti R.   Fumagalli R.  

Pharmacological Research, Vol. 33, Iss. 1, 1996-01 ,pp. : 55-61

Academic Press

Access to resources Recommend Favorite

Conditional Cardiac Overexpression of S100A6 Attenuates Myocyte Hypertrophy and Apoptosis Following Myocardial Infarction

By  

Current Pharmaceutical Design, Vol. 20, Iss. 12, 2014-04 ,pp. : 1941-1949

Bentham Science Publishers

Access to resources Recommend Favorite